NAVLE Multisystemic

Bovine Pregnancy Toxemia Study Guide

Pregnancy toxemia (also known as ketosis of pregnancy or fat cow syndrome) is a metabolic disease occurring in late gestation cattle, characterized by inadequate glucose homeostasis leading to negative energy balance, ketosis, and hepatic lipidosis.

Overview and Clinical Importance

Pregnancy toxemia (also known as ketosis of pregnancy or fat cow syndrome) is a metabolic disease occurring in late gestation cattle, characterized by inadequate glucose homeostasis leading to negative energy balance, ketosis, and hepatic lipidosis. This condition is more common in beef cattle than dairy cattle due to differences in dietary management and timing of late gestation coinciding with poor feed availability.

The disease develops when maternal glucose production cannot meet the energy demands of the rapidly growing fetus, particularly during the last 2 months of gestation. Pregnancy toxemia carries a guarded to grave prognosis, especially in recumbent animals, making early recognition and prevention essential for NAVLE success.

Metabolic Change Consequence and Clinical Significance
Hypoglycemia Glucose less than 2.5 mmol/L; CNS depression, weakness; cerebral hypoglycemia contributes to neurologic signs
Hyperketonemia BHB greater than 1.5 mmol/L; appetite suppression, metabolic acidosis, fruity breath odor (acetone)
Elevated NEFA NEFA greater than 0.6 mmol/L; reflects negative energy balance and fat mobilization; precursor to hepatic lipidosis
Hepatic Lipidosis Yellow, friable liver at necropsy; impaired gluconeogenesis and hepatic function; elevated liver enzymes (AST, GGT)
Metabolic Acidosis Decreased blood pH due to ketone body accumulation; contributes to depression and organ dysfunction
Secondary Electrolyte Imbalances Hypocalcemia, hypophosphatemia, hypokalemia common; may complicate clinical picture and worsen prognosis

Etiology and Pathophysiology

Underlying Mechanism

The pathophysiology of bovine pregnancy toxemia centers on disruption of maternal glucose homeostasis during a period of maximum fetal energy demand. The gravid uterus and fetoplacental unit are major consumers of maternal glucose, with glucose accounting for approximately 50-60% of fetal-placental energy substrates and amino acids providing an additional 30-40%.

During periods of maternal undernutrition:

  • Dietary energy intake becomes insufficient to meet metabolic demands
  • Low insulin concentrations allow increased adipose tissue mobilization
  • Non-esterified fatty acids (NEFAs) are released and transported to the liver
  • Excessive NEFA uptake overwhelms hepatic oxidative capacity
  • NEFAs are re-esterified and deposited as triglycerides causing hepatic lipidosis
  • Excess acetyl-CoA is shunted toward ketone body production (acetoacetate, beta-hydroxybutyrate, acetone)

Key Metabolic Derangements

NAVLE TipRemember the mnemonic 'PREGNANT COW' for pathophysiology: Poor nutrition leads to Reduced glucose, Elevated NEFA, Gluconeogenesis impairment, Negative energy balance, Acetyl-CoA accumulation, Nervous signs from hypoglycemia, Triglyceride deposition in liver, Coma (terminal), Oxaloacetate depletion, Weight loss rapid.
Risk Factor Mechanism and Clinical Relevance
Overconditioned (Obese) Cows BCS greater than 4 (1-5 scale); rapid fat mobilization overwhelms hepatic capacity; decreased appetite due to abdominal fat accumulation reducing rumen capacity
Twin Pregnancies Double fetal energy demand; increased glucose requirements; reduced rumen capacity from enlarged uterus
Inadequate Nutrition Low energy or protein feed; high poorly digestible fiber; poor quality forage during late gestation winter feeding
Environmental Stress Cold, snowy weather increases energy requirements while covering available forage; transport stress
Concurrent Disease Lameness, oral disease, parasitism, or other conditions that increase energy demand or decrease feed intake
First-Calf Heifers Additional energy requirements needed for continued growth while supporting pregnancy

Risk Factors and Predisposing Conditions

Primary Risk Factors

Exam Focus: NAVLE questions often describe a late-winter scenario with beef cattle on poor pasture or inadequate hay. The classic patient is an overconditioned cow carrying twins during a period of feed scarcity. Remember that pregnancy toxemia is MORE COMMON in beef cattle than dairy cattle due to management differences.

Stage Clinical Signs
Early Stage Rapid weight loss (body condition loss visible over 1-2 weeks); decreased appetite and rumination; decreased fecal production; decreased nose-licking; separation from herd
Intermediate Stage Marked depression; weakness and ataxia (staggering gait); acetone odor on breath (fruity smell); dull mentation
Advanced/Neurologic Stage Excitability alternating with depression; blindness; ataxia progressing to recumbency; opisthotonos; seizures; aggression or delirium may occur
Terminal Stage Sternal recumbency progressing to lateral recumbency; coma; death (usually within 3-10 days of clinical onset without treatment)

Clinical Signs and Physical Examination

Progression of Clinical Signs

Clinical signs typically develop over 1-2 weeks and progress through distinct stages. Early recognition is critical as advanced cases rarely respond to treatment.

High-YieldThe neurologic signs in bovine pregnancy toxemia (depression, excitability, ataxia, blindness) result from CEREBRAL HYPOGLYCEMIA combined with ketoacidosis. This distinguishes it from similar conditions. Unlike dairy cow ketosis which primarily shows decreased milk production, beef cow pregnancy toxemia presents with more prominent neurologic dysfunction.
Parameter Abnormal Value Clinical Significance
Urine Ketones Positive (any level) Most specific early finding; ketonuria should NOT occur in healthy pregnant cows until days before calving
Serum BHB Greater than 1.5 mmol/L Reflects negative energy balance and ketogenesis; most reliable indicator of disease severity
Blood Glucose Less than 2.5 mmol/L (hypoglycemia) Common but not consistent; hyperglycemia may occur with seizures or excitement
Serum NEFA Greater than 0.6 mmol/L Reflects fat mobilization; indicates likely hepatic lipidosis
BUN Less than 3.57 mmol/L Reflects low nutrient intake
Total Protein/Albumin Decreased (less than 50 g/L; albumin less than 22 g/L) Indicates protein catabolism and inadequate intake
Serum Potassium Less than 4 mmol/L Hypokalemia common; contributes to weakness

Diagnosis

Diagnostic Approach

Diagnosis of bovine pregnancy toxemia is based on history, clinical signs, and laboratory findings. A presumptive diagnosis can be made in any cow in late gestation with marginal feed quality presenting with depression and weight loss.

Laboratory Findings

NAVLE TipFor NAVLE: KETONURIA is the MOST SPECIFIC early finding - even mild ketonuria is abnormal in pregnant cows before the final days of gestation. Serum BHB is the MOST RELIABLE indicator of disease severity. Point-of-care glucometers that measure BHB are invaluable field diagnostics.

Differential Diagnosis

Few differential diagnoses exist for pregnancy toxemia in late-gestational cattle, but other periparturient conditions must be considered:

Postmortem Findings

  • Hepatic lipidosis: Enlarged, yellow, friable liver (classic finding)
  • Serous atrophy of fat: Lack of subcutaneous adipose tissue; gelatinous appearance of omental, perirenal, and pericardial fat depots
  • Large or multiple fetuses: Often twins present; fetuses may be dead and decomposing
  • Distended gallbladder
Differential Distinguishing Features
Hypocalcemia (Milk Fever) Typically periparturient; rapid response to IV calcium; no ketonuria; may occur concurrently with pregnancy toxemia
Polioencephalomalacia Cortical blindness with dorsomedial strabismus; responds to thiamine; no ketonuria; not specific to pregnancy
Listeriosis Unilateral cranial nerve deficits; circling; facial paralysis; CSF pleocytosis; not specific to pregnancy
Lead Toxicosis History of lead exposure; elevated blood lead levels; nucleated RBCs with basophilic stippling
Rabies Progressive; behavioral changes; ascending paralysis; always fatal; brain histopathology diagnostic
Hypomagnesemia (Grass Tetany) Hyperexcitability; tetany; convulsions; usually in lactating cattle on lush pasture; low serum magnesium

Treatment

Early intervention is critical - most recumbent cattle do not respond to treatment. Treatment goals include correcting hypoglycemia, suppressing ketogenesis, addressing electrolyte imbalances, and reducing fetal energy drain.

Treatment Protocol by Disease Stage

High-YieldRECUMBENT CATTLE RARELY RESPOND TO TREATMENT - this is a critical NAVLE fact. The decision to treat must weigh prognosis, animal value, and welfare. Induction of parturition or cesarean section should be considered early to reduce fetal energy drain, but this decision should be made in conjunction with the animal's clinical status.
Stage/Condition Treatment Approach
Early/Ambulatory Nutritional support: High quality forage and concentrate Propylene glycol: 0.5-1 g/kg/day PO for up to 5 days (gluconeogenic precursor) Transfaunation: Rumen fluid from healthy animal to stimulate microbial populations
Anorectic/Advanced IV Dextrose: 0.5 g/kg (50% dextrose) at least once daily; 5% dextrose continuous infusion preferred Fluid therapy: 20-60 L/day PO or IV of balanced electrolyte solution for dehydration and acidosis Force-fed propylene glycol: If unable to drench safely
Adjunctive Therapies Calcium supplementation: If hypocalcemia present (calcium gluconate SC or slow IV) Potassium chloride: Oral supplementation for hypokalemia Protamine zinc insulin: 200 U SC every 48 hours after dextrose (suppresses ketogenesis; NOT approved for cattle in US) B vitamins: May stimulate appetite
Surgical Intervention Induction of parturition: Dexamethasone 20-25 mg IM; expect parturition within 24-72 hours Cesarean section: Consider in valuable animals to immediately reduce energy drain; should be combined with supportive care

Prevention and Herd Management

Prevention is critical because treatment success is limited. Herd-level strategies focus on nutritional management and body condition optimization.

Key Prevention Strategies

Exam Focus: NAVLE often tests prevention strategies. Key points: (1) Do NOT allow cows to become overly fat during pregnancy, (2) Do NOT suddenly restrict feed to reduce body condition near term, (3) Target appropriate BCS BEFORE the final trimester, (4) Respond immediately when a single case is identified by improving nutrition for entire herd.

Strategy Implementation Details
Body Condition Monitoring Target BCS greater than 5 (1-9 scale) or greater than 3 (1-5 scale) entering final trimester; avoid both over- and under-conditioning; regular scoring throughout pregnancy
Nutritional Management Feed analysis of forage for energy and protein; minimum 1 kg crude protein/day; additional concentrates for thin cows; NDF intake capacity approximately 1% body weight
Ionophore Supplementation Monensin increases ruminal propionate production for greater glucose availability; beef cattle: up to 180 mg/day; dairy cattle: 115-410 mg/day (not approved in all countries)
Herd Response to Case When one case identified: immediately boost herd nutrition with supplemental feed or quality hay; sort cows by body condition and feed accordingly; at-risk cows may receive prophylactic propylene glycol
Calving Season Management Avoid timing late gestation to coincide with poorest feed availability (late winter); ensure adequate winter forage reserves; plan for cold weather energy needs
Health Management Address concurrent diseases (lameness, dental problems, parasitism) that decrease feed intake; minimize transport and handling stress during late gestation

Prognosis

Prognosis for bovine pregnancy toxemia is guarded to grave, particularly in advanced cases. Key prognostic factors include:

  • Stage at presentation: Early ambulatory cases have better prognosis than recumbent animals
  • Recumbency: Recumbent cattle rarely respond to treatment regardless of interventions
  • Fetal status: Dead or decomposing fetuses worsen prognosis due to secondary toxemia
  • BHB levels: Higher BHB concentrations correlate with more severe disease and poorer outcomes
  • Response to initial treatment: Lack of improvement within 24-48 hours suggests poor prognosis

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →